Marcos J. de Lima

1.7k total citations
41 papers, 910 citations indexed

About

Marcos J. de Lima is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Marcos J. de Lima has authored 41 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Hematology, 12 papers in Oncology and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Marcos J. de Lima's work include Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). Marcos J. de Lima is often cited by papers focused on Hematopoietic Stem Cell Transplantation (25 papers), Acute Myeloid Leukemia Research (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). Marcos J. de Lima collaborates with scholars based in United States, Brazil and Germany. Marcos J. de Lima's co-authors include Richard E. Champlin, G. Body, John P. Whitecar, Chitra Hosing, Issa F. Khouri, Sergio Giralt, Börje S. Andersson, Daniel R. Couriel, Leo Luznik and Christopher G. Kanakry and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marcos J. de Lima

36 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcos J. de Lima United States 16 586 329 273 141 111 41 910
Mats Remberger Sweden 18 583 1.0× 398 1.2× 247 0.9× 132 0.9× 185 1.7× 37 1.1k
Manuel Abecasis Portugal 11 488 0.8× 220 0.7× 198 0.7× 131 0.9× 230 2.1× 24 865
Ken Ishiyama Japan 17 555 0.9× 186 0.6× 266 1.0× 115 0.8× 141 1.3× 100 865
Javier Anguita Spain 16 405 0.7× 177 0.5× 166 0.6× 109 0.8× 122 1.1× 65 688
Barbara Bruno Italy 11 1.1k 1.9× 464 1.4× 498 1.8× 163 1.2× 186 1.7× 18 1.4k
Rémy Duléry France 17 489 0.8× 346 1.1× 196 0.7× 100 0.7× 205 1.8× 89 935
Kazuhiro Masuoka Japan 21 588 1.0× 326 1.0× 378 1.4× 80 0.6× 198 1.8× 50 1.1k
C Ferry France 14 480 0.8× 289 0.9× 154 0.6× 129 0.9× 324 2.9× 26 1.0k
A Gratwohl Switzerland 17 714 1.2× 264 0.8× 328 1.2× 110 0.8× 124 1.1× 59 1.1k
Elisabetta Calore Italy 17 406 0.7× 241 0.7× 138 0.5× 86 0.6× 265 2.4× 37 869

Countries citing papers authored by Marcos J. de Lima

Since Specialization
Citations

This map shows the geographic impact of Marcos J. de Lima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcos J. de Lima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcos J. de Lima more than expected).

Fields of papers citing papers by Marcos J. de Lima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcos J. de Lima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcos J. de Lima. The network helps show where Marcos J. de Lima may publish in the future.

Co-authorship network of co-authors of Marcos J. de Lima

This figure shows the co-authorship network connecting the top 25 collaborators of Marcos J. de Lima. A scholar is included among the top collaborators of Marcos J. de Lima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcos J. de Lima. Marcos J. de Lima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woost, Philip G., Basem M. William, Brenda Cooper, et al.. (2024). Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies. Cytometry Part B Clinical Cytometry. 106(1). 11–24.
2.
Lima, Marcos J. de, et al.. (2024). Endophytic bacteria from lettuce seedlings antagonistic to the phytopathogenic fungus Alternaria sp.. Ciência e Agrotecnologia. 48.
3.
Shah, Manan, et al.. (2023). Promises and challenges of a decentralized CAR T-cell manufacturing model. SHILAP Revista de lepidopterología. 2. 1238535–1238535. 24 indexed citations
4.
William, Basem M., Tao Wang, Michael Haagenson, et al.. (2017). Impact of HLA Alleles on Outcomes of Allogeneic Transplantation for B Cell Non-Hodgkin Lymphomas: A Center for International Blood and Marrow Transplant Research Analysis. Biology of Blood and Marrow Transplantation. 24(4). 827–831. 1 indexed citations
5.
6.
Bear, Adham S., Patrick J. Hanley, Doyle Bosque, et al.. (2014). Low rate of infusional toxicity after expanded cord blood transplantation. Cytotherapy. 16(8). 1153–1157. 6 indexed citations
7.
Kanakry, Christopher G., Paul V. O’Donnell, Terry Furlong, et al.. (2014). Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning. Journal of Clinical Oncology. 32(31). 3497–3505. 170 indexed citations
8.
Karuturi, Meghan, Chitra Hosing, Michelle A. Fanale, et al.. (2013). High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Nodular Lymphocyte-Predominant Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 19(6). 991–994. 26 indexed citations
9.
Aung, Fleur M., Benjamin Lichtiger, Roland L. Bassett, et al.. (2013). Incidence and natural history of pure red cell aplasia in major ABO‐mismatched haematopoietic cell transplantation. British Journal of Haematology. 160(6). 798–805. 40 indexed citations
10.
Yılmaz, Musa, Roy F. Chemaly, Xiaoyan Han, et al.. (2013). Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience. Bone Marrow Transplantation. 48(9). 1218–1223. 28 indexed citations
11.
Morris, Gerwyn, et al.. (2011). Adherence of stem cell transplant recipients receiving glucocorticoid therapy to an exercise-based rehabilitation program. Supportive Care in Cancer. 20(10). 2391–2398. 11 indexed citations
12.
Popat, Uday, Marcos J. de Lima, Rima M. Saliba, et al.. (2011). Long-term outcome of reduced-intensity allogeneic hematopoietic SCT in patients with AML in CR. Bone Marrow Transplantation. 47(2). 212–216. 18 indexed citations
13.
Alatrash, Gheath, Matteo Pelosini, Rima M. Saliba, et al.. (2011). Platelet Recovery Before Allogeneic Stem Cell Transplantation Predicts Posttransplantation Outcomes in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome. Biology of Blood and Marrow Transplantation. 17(12). 1841–1845. 14 indexed citations
14.
Cheng, Yee Chung, Gabriela Rondón, John D. McMannis, et al.. (2009). Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. International Journal of Hematology. 90(5). 627–634. 3 indexed citations
15.
Safdar, Amar, Gilhen Rodriguez, Marcos J. de Lima, et al.. (2007). Infections in 100 Cord Blood Transplantations. Medicine. 86(6). 324–333. 36 indexed citations
16.
Lima, Marcos J. de, Elias Jabbour, Jörge E. Cortes, et al.. (2006). Novel tyrosine kinase inhibitor therapy (NTKI) prior to allogeneic stem cell transplantation (ASCT) in patients (pts) with chronic myeloid leukemia (CML): No evidence for increased transplant-related toxicity. Journal of Clinical Oncology. 24(18_suppl). 16515–16515. 1 indexed citations
17.
Anderlini, Paolo, Sandra Acholonu, Börje S. Andersson, et al.. (2004). Donor leukocyte infusions in relapsed Hodgkin's lymphoma following allogeneic stem cell transplantation: CD3+ cell dose, GVHD and disease response. Bone Marrow Transplantation. 34(6). 511–514. 34 indexed citations
18.
Couriel, Daniel R., Rima M. Saliba, Marcos J. de Lima, et al.. (2004). Hyperacute Graft-Versus-Host Disease: Analysis of Risk Factors, Clinical Manifestations and Outcomes.. Blood. 104(11). 734–734. 1 indexed citations
19.
Vasconcelos, Zilton, Elaine Sobral da Costa, Marcos J. de Lima, et al.. (2003). T-lymphocyte function from peripheral blood stem-cell donors is inhibited by activated granulocytes. Cytotherapy. 5(4). 336–345. 22 indexed citations
20.
Whitecar, John P., Marcos J. de Lima, & G. Body. (1970). Pseudomonas Bacteremia in Patients with Malignant Diseases. The American Journal of the Medical Sciences. 260(4). 216–223. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mats Remberger Breakdown of academic impact, for papers by Manuel Abecasis Breakdown of academic impact, for papers by Ken Ishiyama Breakdown of academic impact, for papers by Javier Anguita Breakdown of academic impact, for papers by Barbara Bruno Breakdown of academic impact, for papers by Rémy Duléry Breakdown of academic impact, for papers by Kazuhiro Masuoka Breakdown of academic impact, for papers by C Ferry Breakdown of academic impact, for papers by A Gratwohl Breakdown of academic impact, for papers by Elisabetta Calore
Rankless by CCL
2026